skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The cytological manifestation of gene amplification in multidrug-resistant mouse leukemia P388 sublines is correlated with amplicon content

Journal Article · · Russian Journal of Genetics
OSTI ID:283141
;  [1];  [2]
  1. Institute of Carcinogenesis, Moscow (Russian Federation)
  2. Institute of Chemical Physics, Moscow (Russian Federation)

Previously, we showed that development of multidrug resistance (MDR) in mouse P388 leukemia cells is often associated with the appearance of newly-formed chromosomelike structures that contain amplified copies of the mdr1 gene. In the present study, we compared amplicon content in P388 sublines showing different types of these structures. A strong correlation between the formation of specific acentric markers consisting of two identical arms and the absence of the sorcin gene coamplification was found. In all the sublines containing other types of chromosomelike structures, the sorcin gene is coamplified. 9 refs., 2 figs., 1 tab.

OSTI ID:
283141
Journal Information:
Russian Journal of Genetics, Vol. 31, Issue 10; Other Information: PBD: Oct 1995; TN: Translated from Genetika; 31: No. 10, 1449-1451(1995)
Country of Publication:
United States
Language:
English

Similar Records

Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction
Journal Article · Sat Sep 01 00:00:00 EDT 1990 · Proceedings of the National Academy of Sciences of the United States of America; (United States) · OSTI ID:283141

Modulation of P-glycoprotein activity by novel synthetic curcumin derivatives in sensitive and multidrug-resistant T-cell acute lymphoblastic leukemia cell lines
Journal Article · Mon Aug 15 00:00:00 EDT 2016 · Toxicology and Applied Pharmacology · OSTI ID:283141

Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells
Journal Article · Tue May 01 00:00:00 EDT 1984 · Cancer Res.; (United States) · OSTI ID:283141